DXCM
Dexcom
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: DXCM
- PEG Ratio
DXCM currently has a PEG ratio reading of 0.37 as of Jun 22, 2026. Dividing the 28.78 PE ratio by the 77.8% earnings growth rate yields this valuation metric.
DXCM PEG ratio history
A eight years lookback shows an average PEG ratio of 2.26 for Dexcom. Compared to historical data, DXCM's 0.37 PEG ratio represents a decrease of 84%. The eight years high occurred in the Dec 2024 quarter at 12.39, reflecting maximum valuation relative to growth. The minimum was hit in the Dec 2020 quarter at 0.15, indicating optimal value relative to growth during that period.
Dexcom PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.67 | 31.01 | 46.6% |
| 2024 | 12.39 | 53.27 | 4.3% |
| 2023 | 1.5 | 88.64 | 59.1% |
| 2022 | 2.25 | 128.68 | 57.1% |
| 2021 | N/A | 239.71 | -61.6% |
| 2020 | 0.15 | 63.31 | 421.4% |
| 2019 | 1.1 | 195.3 | 177.8% |
| 2018 | N/A | N/A | -140% |
| 2017 | N/A | N/A | 25% |
| 2016 | N/A | N/A | -11.1% |
| 2015 | N/A | N/A | -125% |
| 2014 | N/A | N/A | 27.3% |
| 2013 | N/A | N/A | 45% |
| 2012 | N/A | N/A | -17.6% |
| 2011 | N/A | N/A | 29.2% |
Dexcom PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.34 | 26.17 | 77.8% |
| Dec 2025 | 0.67 | 31.01 | 46.6% |
| Sep 2025 | 6.42 | 36.57 | 5.7% |
| Jun 2025 | N/A | 60.2 | -15.2% |
| Mar 2025 | N/A | 50.59 | -18.2% |
| Dec 2024 | 12.39 | 53.27 | 4.3% |
| Sep 2024 | 0.5 | 38.53 | 77.6% |
| Jun 2024 | 0.79 | 66.3 | 83.9% |
| Mar 2024 | 0.72 | 84.06 | 117.1% |
| Dec 2023 | 1.5 | 88.64 | 59.1% |
| Sep 2023 | 1.71 | 95.2 | 55.6% |
| Jun 2023 | 2.51 | 138.18 | 55% |
| Mar 2023 | 11.41 | 152.87 | 13.4% |
| Dec 2022 | 2.25 | 128.68 | 57.1% |
| Sep 2022 | N/A | 127.84 | -62.3% |
DXCM average PEG ratio chart
When comparing to historical values, DXCM's PEG ratio is below the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 0.37, DXCM stands below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.55, Dexcom's PEG is 33% lower.
DXCM EPS growth
DXCM Price vs fair value
DXCM PEG vs peers
DXCM has a PEG ratio below that of peer stocks MDT and WST.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| DXCM Dexcom Inc | 0.37 | $26.59B |
| WST West Pharmaceutical Services Inc | 2.62 | $23.77B |
| MDT Medtronic plc | 6.52 | $103.21B |
| EW Edwards Lifesciences Corp | N/A | $50.07B |
| BDX Becton Dickinson & Co | N/A | $39.66B |
| TNDM Tandem Diabetes Care Inc | N/A | $987.5M |
| ABT Abbott Laboratories | N/A | $157.69B |
| QDEL Quidel Corp | N/A | $813.86M |
| JNJ Johnson & Johnson | N/A | $575.52B |
Frequently asked questions
What is Dexcom's PEG ratio?
DXCM's Jun 22, 2026 PEG ratio comes in at 0.37.
What is the 3-year average PEG ratio for Dexcom (DXCM)?
DXCM's 3-year PEG ratio average stands at 2.76.
What is the 5-year average PEG ratio for Dexcom (DXCM)?
DXCM's 5-year PEG ratio average stands at 3.0.
What is the highest PEG ratio for DXCM?
In the last eight years, DXCM's peak PEG ratio of 12.39 was recorded in the Dec 2024 quarter.
How does the current PEG ratio for DXCM compare to its historical average?
Compared to the 8-year average, DXCM's PEG ratio is 84% lower.
Why is Dexcom's PEG ratio so low?
At 0.37, DXCM's PEG ratio suggests the stock may be attractively priced given its growth rate.
How is DXCM's PEG ratio calculated (Dexcom PEG ratio formula)?
PEG equals PE divided by EPS growth (YoY TTM). As of Jun 22, 2026, Dexcom has a P/E ratio of 28.78. Earnings grew at 77.8% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 0.37. PEG RATIO(0.37) = PE RATIO(28.78) / EPS GROWTH(77.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.